Related Experiment Video

Updated: Aug 7, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Chlamydia pneumoniae as a respiratory pathogen

David L Hahn1, Anthony A Azenabor, Wandy L Beatty

  • 1Arcand Park Clinic, Dean Medical Center, Madison WI 53704, USA.

Frontiers in Bioscience : a Journal and Virtual Library
|February 28, 2002
PubMed

Insights

Chlamydia pneumoniae causes respiratory infections, often asymptomatic but sometimes severe. Persistent forms are antibiotic-resistant and linked to chronic lung diseases like asthma and COPD.

Area of Science:

  • Microbiology
  • Immunology
  • Respiratory Medicine

Background:

  • Chlamydia pneumoniae is a significant human respiratory pathogen.
  • It exhibits a unique biphasic life cycle with intracellular replicative and extracellular infectious forms.
  • The organism infects a majority of the global population via the respiratory route.

Purpose of the Study:

  • To investigate the role of Chlamydia pneumoniae in acute and chronic respiratory illnesses.
  • To understand the characteristics of persistent C. pneumoniae infections and their link to chronic lung diseases.
  • To highlight the need for improved diagnostics and treatments for C. pneumoniae.

Main Methods:

  • The study reviews the life cycle and clinical manifestations of C. pneumoniae infections.
  • It discusses the biological behavior of persistent intracellular inclusions, including heat shock protein 60 (hsp 60) expression.
  • Evidence linking C. pneumoniae infection to chronic inflammatory lung diseases is examined.

Main Results:

  • Most acute C. pneumoniae infections are asymptomatic (70%) or mild, but a minority (30%) lead to severe respiratory illnesses like pneumonia and bronchitis.
  • Persistent C. pneumoniae inclusions are metabolically inert, antibiotic-resistant, and associated with prolonged symptoms.
  • Increased chlamydial hsp 60 in persistent infections is implicated in chronic inflammatory disease pathogenesis.

Conclusions:

  • Chlamydia pneumoniae infection is linked to a spectrum of chronic inflammatory lung diseases, including asthma, chronic bronchitis, and COPD.
  • Effective treatment of acute C. pneumoniae infection and understanding its role in chronic lung conditions require further research.
  • Development of reliable diagnostics and antibiotics effective against persistent C. pneumoniae is crucial.

More Related Videos

The Bovine Lung in Biomedical Research: Visually Guided Bronchoscopy, Intrabronchial Inoculation and In Vivo Sampling Techniques09:01

The Bovine Lung in Biomedical Research: Visually Guided Bronchoscopy, Intrabronchial Inoculation and In Vivo Sampling Techniques

Published on: July 3, 2014

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...